AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Immunotherapeutic approaches in ovarian cancer reviewed.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Immunologic principles and immunotherapeutic approaches in ovarian cancer have been reviewed in a recent issue of Hematology - Oncology Clinics of North America.
According to researchers in the United States, "Ovarian tumors are immunogenic, and several ovarian-related antigens have been identified. The immunologic characteristics of the tumor microenvironment that may affect ovarian cancer growth are becoming increasingly understood."
"The type of immune-based approach selected to treat ovarian cancer depends on the tumor burden," said Keith L. Knutson and colleagues at the University of Washington in Seattle. "For minimal disease states, active vaccination may be useful for generating adequate protection from relapse. For more advanced stage disease states, more rigorous strategies may need to be applied, such as adoptive T-cell therapy, cytokine infusions, antibody therapy, or a combination of different techniques. The immunosuppressive environment observed during ...
- Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special...
- Press release article from: PR Newswire March 23, 2009 700+ words
...Corporation of North America, announced today...platinum-sensitive ovarian cancer patients experiencing...globally at sites in North America, South America...Australia and Asia. "Ovarian cancer is a disease that...000 cases of ovarian cancer each year. ...
- Tubal Ligation Shown to Reduce Incidence of Ovarian Cancer for BRCA1 Carriers.
- Magazine article from: Internal Medicine Alert July 15, 2001 700+ words
...1470. The lifetime risk for ovarian cancer in women who carry mutations...About 10% of all new cases of ovarian cancer in North America are associated with mutations...risk of invasive epithelial ovarian cancer, but risk reduction had not...
- Research on ovarian cancer published by M. Terplan et al.
- Newspaper article from: Cancer Weekly September 22, 2009 700+ words
...of racial disparities in ovarian cancer, we undertook a systematic...States report (see also Ovarian Cancer). "Focusing on North America, our search of MEDLINE...of surgical treatment for ovarian cancer [pooled relative risk...
- Studies from University of Pittsburgh, Nursing Department in the area of...
- Newspaper article from: Cancer Weekly October 20, 2009 700+ words
...for women with recurrent ovarian cancer, is introduced." Dumrongpakapakorn...study in Nursing Clinics of North America (Computer-Mediated Patient...for Supporting Women with Ovarian Cancer. Nursing Clinics of North America, 2009;44(3):339...
- Correlogic Systems Licenses Ovarian Cancer Diagnostic Test to Quest Diagnostics...
- Press release article from: PR Newswire November 6, 2002 700+ words
...including stage one ovarian cancer -- the earliest and most...potentially lifesaving ovarian cancer test available to women across North America. "We look forward to...technology to women at risk for ovarian cancer and their physicians...
- Ovarian cancer risk in relation to medical visits, pelvic examinations and type...
- Magazine article from: Canadian Medical Association. Journal Abenhaim, Haim A; Titus-Ernstoff, Linda; Cramer, Daniel W March 27, 2007 700+ words
...observed an increased risk of ovarian cancer among women who, during the...of health care provider and ovarian cancer is unknown, women should...2007;176(7):941-7 In North America, ovarian cancer is the second most common...
- In Support of National Ovarian Cancer Awareness Month ... Kelly Ripa Launches...
- Press release article from: PR Newswire September 3, 2008 700+ words
...September is Ovarian Cancer Awareness Month...collection in North America. At the centerpiece...to help fight ovarian cancer over the next...President and CEO, North America, Keith McLoughlin. "National Ovarian Cancer Awareness Month...
- Morphotek[R], Inc. Announces Initiation of Farletuzumab Phase II Study In...
- Press release article from: Business Wire December 2, 2008 700+ words
...Platinum-Resistant Ovarian Cancer EXTON, Pa...Corporation of North America, today announced...clinical centers in North America, South America...platinum-resistant ovarian cancer," stated Martin...European Union, ovarian cancer is estimated ...
Source: HighBeam Research, Immunotherapeutic approaches in ovarian cancer reviewed.